Abstract
Barrett's esophagus (BE) is a known precursor to esophageal adenocarcinoma. In the United States, a prevalence of up to 25% is reported in high risk populations and it is identified in about 5% of patients with gastroesophageal reflux disease (GERD). The diagnosis of BE requires endoscopically identifying columnar (“salmon colored”) mucosa, taking biopsies from targeted areas and then confirming histologically. The American College of Gastroenterologists updated its criteria in 2016, introducing a length requirement. This brief review addresses diagnosis of BE and its various associated challenges; identifying dysplasia, grading it, and management.
Original language | English (US) |
---|---|
Pages (from-to) | 479-486 |
Number of pages | 8 |
Journal | Diagnostic Histopathology |
Volume | 24 |
Issue number | 12 |
DOIs | |
State | Published - Dec 2018 |
Keywords
- Barrett's esophagus
- dysplasia
- gastroesophageal junction
- management
- z-line
ASJC Scopus subject areas
- Pathology and Forensic Medicine
- Histology